Difference between revisions of "Team:Uppsala/Human Practices"
| Line 5: | Line 5: | ||
{{Uppsala/javascript/scroll-button}} | {{Uppsala/javascript/scroll-button}} | ||
{{Uppsala/javascript/redirect_js}} | {{Uppsala/javascript/redirect_js}} | ||
| + | {{Uppsala/nav}} | ||
| Line 55: | Line 56: | ||
<br> | <br> | ||
| + | <p> To read the complete market analysis, please follow this link | ||
| + | <a href=" https://2018.igem.org/Team:Uppsala/Human_Practices/Market_Analysis " > [click here] </a> | ||
| + | |||
| + | </p> | ||
| Line 66: | Line 71: | ||
<p> Here is a second paragraph with <i>E.coli</i> written in italics. Any found genes which display promise will have to be validated by qPCR (which is a similar method) in a second run to confirm that they are only expressed due to the strongyle presence. Another approach to tackle our challenge is to screen for interaction between the surface proteins on the strongyle and short peptides. Through affinity screening of a random peptide library displayed on the surface of phages, we can select a peptide with a high affinity to the nematodes surface. </p> | <p> Here is a second paragraph with <i>E.coli</i> written in italics. Any found genes which display promise will have to be validated by qPCR (which is a similar method) in a second run to confirm that they are only expressed due to the strongyle presence. Another approach to tackle our challenge is to screen for interaction between the surface proteins on the strongyle and short peptides. Through affinity screening of a random peptide library displayed on the surface of phages, we can select a peptide with a high affinity to the nematodes surface. </p> | ||
</div> | </div> | ||
| + | |||
Revision as of 17:17, 14 October 2018
Market Analysis
The iGEM project started with a brainstorm session to decide in which direction we wanted our project to go. But before starting with our project, we had some crucial questions that needed to be answered. What tools are accessible today and what are their limits? Is there a market for a new diagnostic tool with our approach? Is there a need for a new diagnostic tool for large strongyles as well? How do the potential stakeholder or customer feel about using a diagnostic tool based on GMO?
To answer these questions we chose to proceed by setting up a meeting with the company Vidilab (a Swedish company working with diagnostics of parasites such as strongyles). Vidilab are everyday users of the current diagnostic tools thus are deeply involved and experienced within the area of our project, making them great consultants.
In addition, we conducted a survey to receive greater understanding of the individual perspective of the respondents. The survey was translated into 10 different languages, see table 1 .
INSERT TABLE HERE!!
To read the complete market analysis, please follow this link [click here]
The header I want I put here
The text that I want will be here, in between these tags
Here is a second paragraph with E.coli written in italics. Any found genes which display promise will have to be validated by qPCR (which is a similar method) in a second run to confirm that they are only expressed due to the strongyle presence. Another approach to tackle our challenge is to screen for interaction between the surface proteins on the strongyle and short peptides. Through affinity screening of a random peptide library displayed on the surface of phages, we can select a peptide with a high affinity to the nematodes surface.